Summary of studies reporting ERCC1 expression and outcomes in non-small cell and small-cell lung cancer patients.

RTqPCR, reverse transcriptase quantitative polymerase chain reaction; IHC, immunohistochemistry; MIC, mitomycin/ifosfamide/cisplatin; MVP, mitomycin/vinblastine/cisplatin; chemoRT, chemoradiotherapy; NS, not stated;*, number of patients assessable for ERCC1 expression and overall survival;ƒ, one patient received adjuvant chemoradiotherapy;⌋, % high ERCC1 expression overall (data not stated for subgroups separately).